rash from tirzepatide Tirzepatide-Induced Injection Site Reaction tirzepatide face rash Exploring the

Side Effects Common: Nausea, vomiting, diarrhea, constipation, abdominal discomfort, decreased appetite, headache

A simple check: if your concentration is 10 mg/mL and you need 5 mg, your volume should be less than 1 mL

If you switched vials, changed compounding pharmacies, or have been using the same reconstituted vial for over 30 days, suspect potency degradation rather than true tolerance

Patients treated with subcutaneous semaglutide (0.5 mg once weekly) can be transitioned to oral semaglutide (7 mg or 14 mg once daily) [24], and can be initiated up to 7 days after their last injection

The company recommends most patients begin with the 4-month "Jumpstart" program